Current weight-loss methods and popular therapies like Wegovy and Zepbound result in both fat and muscle loss, which could be especially harmful for older patients.
Read More Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Tag: Zepbound
Ozempic copies restricted after US judge denies injunction
A U.S. judge rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk’s popular drugs Ozempic and Wegovy while a legal challenge over drug shortages unfolds.
Read More Ozempic copies restricted after US judge denies injunction
Nasdaq touches over one-month low after weak consumer sentiment data
The tech-heavy Nasdaq led Wall Street declines, hitting a six-week low after fresh economic data indicated a deterioration in consumer sentiment.
Read More Nasdaq touches over one-month low after weak consumer sentiment data
U.S. Obesity Rate Declines In 2023 Amid Rising Use Of Weight Loss Products
The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of weight loss drugs such as Ozempic, a new study has found.
Read More U.S. Obesity Rate Declines In 2023 Amid Rising Use Of Weight Loss Products
Tech rally drives S&P 500, Nasdaq to record highs; Powell comments in focus
Wall Street’s main indexes climbed on Wednesday, while investors awaited comments from Federal Reserve Chair Jerome Powell later in the day.
Read More Tech rally drives S&P 500, Nasdaq to record highs; Powell comments in focus
Eli Lilly’s obesity drug now available in U.S. pharmacies
Eli Lilly said its recently approved obesity treatment Zepbound is now available in U.S. pharmacies.
Read More Eli Lilly’s obesity drug now available in U.S. pharmacies